Oxford Instruments Reports Full-Year Growth and Strategic Progress

Oxford Instruments Delivers Robust Growth Amid Strategic Shakeup

If scientific innovation were a relay race, Oxford Instruments just handed the baton to its investors with a confident wink. Today’s trading update reveals a company firing on multiple cylinders – hitting financial targets while executing a strategic pivot that’d make an Olympic gymnast proud.

The Numbers That Matter

Let’s cut straight to the figures that’ll have spreadsheets humming across the City:

• 9% revenue growth at constant currency (6% actual) – proving that science pays even when FX rates don’t cooperate
• 13% surge in adjusted operating profit – because margin expansion isn’t just for textbooks
• 70 basis points of group margin improvement – the financial equivalent of squeezing blood from a quantum stone

But here’s where it gets truly interesting – this isn’t growth through brute force. The 3% order intake increase suggests disciplined commercial execution rather than desperate discounting.

Division Deep Dive: Where the Magic Happens

Imaging & Analysis – The Cash Engine

This segment isn’t just carrying the team – it’s doing victory laps around the competition. Accounting for 66% of group revenue and a staggering 90% of operating profit, these folks are maintaining 24%+ operating margins while still growing. The semiconductor and materials analysis units are clearly eating their Wheaties, offsetting healthcare sector softness like seasoned plate-spinners.

Advanced Technologies – The Comeback Kid

Last year’s problem child is this year’s valedictorian. Double-digit revenue growth and a return to profitability in quantum tech? That’s not just progress – it’s borderline alchemy. The compound semiconductor business deserves particular applause, combining new facilities, Tier 1 clients, and margin improvements like a Michelin-starred chef plating up growth.